Multiple Assemblies exist for SMTL entry 4cra
Creating novel F1 inhibitors through fragment based lead generation and structure aided drug design; X-RAY DIFFRACTION 1.80 Å

	SMTL ID 4cra.1 Ligands GLYCEROL; N-[(1S)-2-[(2-amino-5-quinolyl)methylamino]-1-benzyl-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide; SULFATE ION Polypeptides COAGULATION FACTOR XI Oligo-state monomer
	SMTL ID 4cra.2 Ligands GLYCEROL; N-[(1S)-2-[(2-amino-5-quinolyl)methylamino]-1-benzyl-2-oxo-ethyl]-4-hydroxy-2-oxo-1H-quinoline-6-carboxamide; SULFATE ION Polypeptides COAGULATION FACTOR XI Oligo-state homo-trimer